Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Inverness Medical Innovations has reached an agreement with Thermo Fisher Scientific to extend their cardiology products distribution relationship by two years through December 2010.
Subscribe to our email newsletter
The co-exclusive agreement continues to cover all of the cardiology and drugs of abuse rapid test products manufactured by the Biosite subsidiary of Inverness and sold under the Triage brand including tests for brain natriuretic peptide (BNP), troponin, CK-MB, Myoglobin, d-dimer and a broad range of meter and visually read drugs of abuse tests.
However, products sold for use on third party instruments such as the BNP test sold by Inverness for use on Beckman immunoassay systems are not included.
Ron Zwanziger, CEO of Inverness, said: “Inverness has enjoyed a long and successful relationship with Thermo Fisher Scientific and very much values their expertise in distribution to the clinical laboratory. We are very pleased to extend this agreement for our Triage product line and look forward to a continuing strong affiliation.”